TXNRD1 Antikörper (AA 161-647)
-
- Target Alle TXNRD1 Antikörper anzeigen
- TXNRD1 (Thioredoxin Reductase 1 (TXNRD1))
-
Bindungsspezifität
- AA 161-647
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser TXNRD1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF)
- Immunogen
- Recombinant human TXNRD1 (161-647aa) purified from E. coli
- Klon
- AT30F1
- Isotyp
- IgG2b kappa
- Top Product
- Discover our top product TXNRD1 Primärantikörper
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Lagerung
- 4 °C,-20 °C,-80 °C
- Informationen zur Lagerung
- Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.
-
- Target
- TXNRD1 (Thioredoxin Reductase 1 (TXNRD1))
- Andere Bezeichnung
- Thioredoxin Reductase 1/TRXR1 (TXNRD1 Produkte)
- Hintergrund
- TXNRD1, also known as Thioredoxin reductase 1, is a part of a selenium-containing pyridine nucleotidedisulphide oxidoreductase family, which has a conserved catalytic site of Cys-Val-Asn-Val-Gly-Cys. This protein reduces thioredoxins as well as other substrates, and plays a role in selenium metabolism and protection against oxidative stress. Inhibition of TXNRD1 activity may provide for potential treatments of cancer, AIDS and other autoimmune diseases as well as bacterial infections and parasitic diseases.
- NCBI Accession
- NP_001087240
- Pathways
- Regulation of Lipid Metabolism by PPARalpha, Regulation of Carbohydrate Metabolic Process, Cell RedoxHomeostasis
-